Found: 7
Select item for more details and to access through your institution.
AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.
- Published in:
- Journal of Neurochemistry, 2013, v. 125, n. 3, p. 446, doi. 10.1111/jnc.12203
- By:
- Publication type:
- Article
Safety and tolerability of BAN2401 - a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0181-2
- By:
- Publication type:
- Article
Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2014, v. 6, n. 2, p. 1, doi. 10.1186/alzrt246
- By:
- Publication type:
- Article
Mechanism-based PK-PD model for the prolactin biological system response following an acute dopamine inhibition challenge: quantitative extrapolation to humans.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2012, v. 39, n. 5, p. 463, doi. 10.1007/s10928-012-9262-4
- By:
- Publication type:
- Article
Comparison of the agonist-antagonist interaction model and the pool model for the effect of remoxipride on prolactin G. Ma et al. Comparison of the agonist-antagonist interaction model and the pool model.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 70, n. 6, p. 815, doi. 10.1111/j.1365-2125.2010.03758.x
- By:
- Publication type:
- Article
An Open Study of Clomethiazole in Patients with Acute Cerebral Infarction.
- Published in:
- Cerebrovascular Diseases, 1998, v. 8, n. 3, p. 188, doi. 10.1159/000015846
- By:
- Publication type:
- Article
Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61691-2
- By:
- Publication type:
- Article